Free Trial
LON:VAL

ValiRx (VAL) Share Price, News & Analysis

ValiRx logo
GBX 0.59 +0.04 (+7.27%)
As of 09:54 AM Eastern

About ValiRx Stock (LON:VAL)

Key Stats

Today's Range
0.50
0.60
50-Day Range
0.40
0.60
52-Week Range
0.38
3.50
Volume
593,540 shs
Average Volume
5.54 million shs
Market Capitalization
£2.24 million
P/E Ratio
N/A
Dividend Yield
0.63%
Price Target
N/A
Consensus Rating
N/A

Company Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Receive VAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ValiRx and its competitors with MarketBeat's FREE daily newsletter.

VAL Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
ValiRx plc Announces Change in Major Shareholdings
ValiRx Extends LOI for VAL201 Sub-License
See More Headlines

VAL Stock Analysis - Frequently Asked Questions

ValiRx's stock was trading at GBX 0.65 on January 1st, 2025. Since then, VAL shares have decreased by 9.2% and is now trading at GBX 0.59.
View the best growth stocks for 2025 here
.

ValiRx plc (LON:VAL) announced its earnings results on Monday, September, 7th. The company reported ($4.43) EPS for the quarter. ValiRx had a negative trailing twelve-month return on equity of 55.84% and a negative net margin of 20,554.01%.

Shares of VAL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that ValiRx investors own include Petrofac (PFC), boohoo group (BOO), ReNeuron Group (RENE), Falanx Group (FLX), Lloyds Banking Group (LLOY), IQE (IQE) and Scirocco Energy Plc (SOLO.L) (SOLO).

Company Calendar

Last Earnings
9/07/2020
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Petroleum And Natural Gas
Current Symbol
LON:VAL
CIK
N/A
Fax
N/A
Employees
5,450
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.71 million
Net Margins
-20,554.01%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£27,777.32
Cash Flow
GBX 0.01 per share
Price / Cash Flow
62.50
Book Value
GBX 2.67 per share
Price / Book
0.22

Miscellaneous

Free Float
N/A
Market Cap
£2.24 million
Optionable
Not Optionable
Beta
0.59
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:VAL) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners